Extrapulmonary sarcoidosis.
Sarcoidosis can affect any organ in the body. Frequently extrapulmonary manifestations of the disease are the major cause of morbidity. Treatment of extrapulmonary sarcoidosis often requires consideration of alternative immunosuppressive agents, topical therapy, or therapy that is not specifically directed against the granulomatous inflammation of the disease. This article reviews the clinical presentation and therapy of extrapulmonary sarcoidosis.
Judson
Marc A
MA
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29466, USA. judsonma@musc.edu
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001847:Bone Diseases / Q000473:pathology; D009202:Cardiomyopathies / Q000473:pathology; D005128:Eye Diseases / Q000473:pathology; D006099:Granuloma / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007592:Joint Diseases / Q000473:pathology; D008107:Liver Diseases / Q000473:pathology; D009422:Nervous System Diseases / Q000473:pathology; D015995:Prevalence; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D012871:Skin Diseases / Q000473:pathology; D013158:Splenic Diseases / Q000473:pathology
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents